Skip to main content
. Author manuscript; available in PMC: 2015 Jan 8.
Published in final edited form as: J Endocrinol Diabetes Obes. 2014 Oct;2(4):1057.

Table 6.

Reasons for Withdraw, Randomized Subjects.

Reason for Withdrawal D-tagatose 2.5g
N = 57
n (%)
D-tagatose 5.0g
N = 51
n (%)
D-tagatose 7.5g
N = 53
n (%)
Total
N = 161
n (%)
Subject Request 3 (5.3%) 5 (9.8%) 10 (18.9%) 18 (11.2%)
Lost to Follow-up 3 (5.3%) 3 (5.9%) 5 (9.4%) 11 (6.8%)
AE/SAE 5 (8.8%) 2 (3.9%) 1 (1.9%) 8 (5.0%)
Protocol Deviation 3 (5.3%) 2 (3.9%)* 2 (3.8%) 7 (4.3%)
Termination by Sponsor 2 (3.5%) 0 (0.0%) 0 (0.0%) 2 (1.2%)
Other 6 (10.5%) 7 (13.7%) 1 (1.9%) 14 (8.7%)
Total Withdrawn 22 (38.6%) 19 (37.3%) 19 (35.8%) 60 (37.3%)

N = Randomized subjects; denominator for all percentages

*

One randomized subject in this dose group had a recorded reason for withdrawal of “screen failure” and was therefore tabulated with those withdrawn for a protocol deviation

One randomized subject in this dose group had no reason for withdrawal specified on the CRF and was therefore tabulated with “Other”